Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Careium

28.80 SEK-1.37 %30.10. klo 13.59
Less than 1K followers

CARE

First North Stockholm

Hardware Manufacturer

Technology

Overview
Financials & Estimates
Ownership
Dividend
Short Selling
Investor views
Compare
-1.37 %
+7.46 %
-1.03 %
+22.55 %
+21.01 %
+5.88 %
+40.49 %
-
-10.28 %

Careium offers security solutions such as security alarms, smart sensors and digital visits, with its own alarm center that is staffed 24/7. The product offering includes security alarms, sensors and accessories such as cameras and electronic locks. The company targets private individuals, municipalities and care organizations, and is active in several countries in Europe. The company is headquartered in Malmö, Sweden.

Read more
Market cap
700.59M SEK
Turnover
83.57K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Webcasts
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
11.2.
2027

Annual report '26

22.4.
2027

General meeting '27

22.4.
2027

Interim report Q1'27

Third party research23.10.2026 klo 08.07

Careium: Scaling as promised - ABG

* Favourable market and good cost control * We raise our '26-'27 EBITA estimates by 5-6% * We raise our FVR to SEK 24-37 (20-34) High-quality beat Q3 was strong across the board, with 20% organic growth for SEK 260m in sales. The EBITA margin increased...

Careium
Regulatory press release22.10.2026 klo 16.45

Nomination Committee appointed for Careium’s Annual General Meeting 2027

Careium
Third party research22.10.2026 klo 09.24

Careium: A clean beat with no asterisks - ABG

* Q3 sales 6% above our ests. at SEK 260m, for 20% org. growth * EBITA SEK 27m vs. ABGSCe 20m * Trading at 9x-7x '27e-'28e EV/EBITA adj. An unexpected, but welcome, double-digit margin The Q3 report came in above our estimates for both sales and earnings...

Careium

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release22.10.2026 klo 08.00

Careium reports thirds quarter results 2026

Careium
Press release08.10.2026 klo 09.00

Invitation to presentation of Careium’s third quarter report 2026

Careium
Third party research23.09.2026 klo 08.29

Careium: Not much should rock the Q3 boat - ABG

* Q3e: 13.5% organic sales growth, 8% EBITA margin * H2 faces fewer GM headwinds * Trading at 9x '27e EV/EBITA Strong GM, but growth investments might sting a bit We expect 13.5% organic growth in Q3e despite facing a much tougher comp than the previous...

Careium
Third party research13.07.2026 klo 07.58

Careium: The pressure valve starting to open - ABG

* Strong growth, margin squeeze softer than expected * We raise our '26-'28 EBIT estimates by 3-4% * Share is trading at 13x-8x '26e-'28e EV/EBIT A beat on all accounts Q2 was a strong quarter in terms of growth, with SEK 251m in sales, representing ...

Careium
Third party research10.07.2026 klo 09.44

Careium: Growth's comeback tour continues - ABG

* Q2 sales 10% above our ests. at SEK 251m, for 26% org. growth * Adj. EBIT SEK 15m vs. ABGSCe 10m * Trading at 12x-9x '26e-'27e EV/EBITA adj. An exceptional growth quarter on a forgiving comp Q2 came in better than expected on all accounts. Careium ...

Careium
Regulatory press release10.07.2026 klo 08.00

Careium reports second quarter results 2026

Careium
Regulatory press release09.07.2026 klo 14.42

Careium repays hybrid loan to simplify capital structure

Careium
Press release06.07.2026 klo 09.00

Invitation to presentation of Careium’s second quarter report 2026

Careium
Third party research16.06.2026 klo 09.16

Careium: Growth's necessary trade-off - ABG

* Q2e: 13% organic sales growth, 4.5% EBITA margin * We raise opex on increased competition * Trading at 11.5x '26e EV/EBITA Q2e will likely mirror Q1 We expect another strong quarter from Careium in terms of organic growth y-o-y due to the easy comps...

Careium
Regulatory press release12.05.2026 klo 17.45

Careium signs national framework agreement with Adda in Sweden for welfare technology

Careium
Third party research24.04.2026 klo 08.17

Careium: Relief around the corner - ABG

* Underlying development looks promising * We raise our '26-'28 EBIT estimates by 3-1% * Share is trading at 10x-7x '26e-'28e EV/EBIT Margins not as soft as expected Q1 came in 2% (SEK 4m) above our expectations on sales, for a solid organic growth of...

Careium
Regulatory press release23.04.2026 klo 15.05

Report from Annual General Meeting in Careium AB (publ)

Careium
Third party research23.04.2026 klo 09.59

Careium: Strong growth makes up for elevated costs - ABG

* Q1 sales 2% above our ests. at SEK 220m, for 11% org. growth * Adj. EBIT SEK 13m vs. ABGSCe 9m * Trading at 10x-7x '26e-'28e EV/EBITA adj. A strong Q1 given ongoing headwinds Q1 came in slightly above expectations on sales, and materially above expectations...

Careium
Regulatory press release23.04.2026 klo 09.00

Careium reports first quarter results 2026

Careium
Press release09.04.2026 klo 09.00

Invitation to presentation of Careium’s first quarter report 2026

Careium
Third party research02.04.2026 klo 08.23

Careium: Entering a growth-focused period - ABG

* Q1e: 10% organic sales growth, 4% adj. EBITA margin * We cut our EBITA estimates by 7-2% * Trading at 9x '26e EV/EBITA Q1e: strong organic growth, but soft margins We expect Q1 to be strong in terms of organic growth, as Careium will no longer face...

Careium
Regulatory press release27.03.2026 klo 14.15

Tove Christiansson joins as CEO of Careium on June 1

Careium